Release date 05-29-2018
Page 1 of 3
Morningstar Analyst Rating
McKesson Corp MCK
.
Last Price
Day Change
Open Price
Day Range
52-Week Range
Proj. Yield
Market Cap
Volume
Avg Vol.
Forward P/E
P/B
P/S
P/CF
$ 142.47
[-3.31 | -2.27 %
$ 144.90
142.39-144.90
134.25-178.86
0.93
29.45 bil
108,377
1.7 mil
11.06
3.01
0.15
7
Dividends
Stock Price 2018-01-01 - 2018-05-28 XNYS:MCK: -10.14|-6.50%
Declared Date Ex-Dividend Date Latest Indicated Dividend Amount Projected Yield
180.00 120.00
26/04/2018 31/05/2018 0.34 0.93 %
60.00
2018
Morningstar’s Take The delivery of pharmaceuticals to consumers encompasses many firms along the supply chain, but McKesson stands out as a premier player. We believe the firm has a wide economic moat...
Fair Value Estimate Consider Buying Consider Selling Fair Value Uncertainty Economic Moat Stewardship Growth Profitability Morningstar Credit Rating
$ 210.00 $ 147.00 $ 283.50 Medium Wide Standard X Z —
Key Stats Price/Earnings TTM Price/Book Price/Sales TTM Rev Growth (3 Yr Avg) Net Income Growth (3 Yr Avg) Operating Margin % TTM Net Margin % TTM ROA TTM ROE TTM Debt/Equity
Stock
Ind Avg
486 3 0.1 5.2 -64.3 1.4
21.9 3 0.2 7.8 32.9 2.1 1.6 5.5 31.1 0.9
0.1 0.6 0.7
Relative to Industry
02/28/2018 11/30/2017 08/30/2017 06/01/2017
Cash Dividends Cash Dividends Cash Dividends Cash Dividends
0.3400 0.3400 0.3400 0.2800
Competitors Name
McKesson Corp AmerisourceBergen Corp Cardinal Health Inc Sinopharm Group Co Ltd H Sinopharm Group Co Ltd ADR Shanghai Pharmaceuticals Holding Co Ltd H
Price
% Chg
TTM Sales $ mil
$142.47 $84.31
-2.27 [ -1.38 [
208,357 159,327
$51.86 $4.38
-1.12 [ 0.23 ]
134,426 43,353
$21.89
-2.41 [
43,353
$2.85
9.62 ]
20,974
Total Analysts:
5.0 Buy
3.0 Hold
1.0 Sell
Ownership Fund Owners Avg
+
Annual
Balance Sheet
Amount
Current
Financials --
Type
Recommendations
-
Income Statement
Recent Dividends & Splits
--
--
Quarterly --
--
Star Rating
% Shares Held
% Total Assets
0.26
3.84
0.15 0.09
1.96 1.91
0.08
1.88
0.06
0.86
— Sentry US Growth and Income X Trimark Income Growth T4 QQQQ QQQQ Sentry Small/Mid Cap Income F RBC O'Shaughnessy US QQ Value GIF Series 1 QQQ HEXAVEST US
Cash Flow In millions except "EPS". Currency in USD.
Insiders
Jorge L. Figueredo Bansi Nagji Kathleen D. Mcelligott Lori A. Schechter Britt Vitalone
©2018 Morningstar. All Rights Reserved. Unless otherwise provided in a separate agreement, you may use this report only in the country in which its original distributor is based. Data as originally reported. The information contained herein is not represented or warranted to be accurate, correct, complete, or timely. This report is for information purposes only, and should not be considered a solicitation to buy or sell any security. Redistribution is prohibited without written permission. To order reprints, call +1 312-696-6100. To license the research, call +1 312-696-6869.
% Change TTM
% Shares Outstanding
8,407 0 445 -4,967 0
0.01 0.00 0.00 0.00 0.00
®
ß
Release date 05-29-2018
Page 2 of 3
McKesson Corp MCK Quote
Stock Type
Last Close 29/05/2018
Fair Value Estimate
Morningstar Rating TM
Aggressive Growth
142.47
$ 210.00
QQQQ
Industry Classification NAICS SIC ISIC
Company Profile Drugs and Druggists' Sundries Merchant Wholesalers (424210) Pharmaceutical and Medicine Industry (3741);Drugs, Drug Proprietaries, and Druggists' Sundries (5122) Manufacture of Pharmaceuticals, Medicinal Chemical and Botanical Products (2100)
Operation Details Fiscal Year Ends CIK Year Established Employees (31/03/2017) Full Time Part Time Auditor (31/03/2018) Legal Advisor (31/03/2010) Key Executives
2019-03-31 927653 78,000 51,000 27,000 Deloitte & Touche LLP Skadden, Arps, Slate, Meagher & Flom Jorge L. Figueredo/Executive Vice President, Human Resources; Bansi Nagji/Executive Vice President, Corporate Strategy and Business Development; Kathleen D. Mcelligott/Executive Vice President, Chief Information Officer and Chief Technology Officer; Lori A. Schechter/Executive Vice President, General Counsel and Chief Compliance Officer; Britt Vitalone/Executive Vice President and Chief Financial Officer; Erin M. Lampert/Senior Vice President and Chief Accounting Officer; John H. Hammergren/Chairman of the Board, President and Chief Executive Officer; Paul A. Smith/Senior Vice President, Taxes; Brian P. Moore/Senior Vice President and Treasurer; Michele Lau/Corporate Secretary
McKesson is one of three major distributors of pharmaceuticals in the U.S. The firm also has significant specialty drug and medical product wholesaling operations. The firm plays a critical role along the pharmaceutical supply chain as it is able to procure and distribute drugs more efficiently than its pharmacy client and pharma manufacturing suppliers. 30-day Avg Volume Market Cap Net Income Sales Sector Industry Stock Style Direct Investment Dividend Reinvestment
©2018 Morningstar. All Rights Reserved. Unless otherwise provided in a separate agreement, you may use this report only in the country in which its original distributor is based. Data as originally reported. The information contained herein is not represented or warranted to be accurate, correct, complete, or timely. This report is for information purposes only, and should not be considered a solicitation to buy or sell any security. Redistribution is prohibited without written permission. To order reprints, call +1 312-696-6100. To license the research, call +1 312-696-6869.
1.8Mil 29.5Bil 67.0Mil 208.4Bil Healthcare Medical Distribution 1 Large Value No Yes
®
ß
Release date 05-29-2018
Page 3 of 3
McKesson Corp MCK Quote
Stock Type
Last Close 29/05/2018
Fair Value Estimate
Morningstar Rating TM
Aggressive Growth
142.47
$ 210.00
QQQQ
Industry Peers
McKesson Corp AmerisourceBergen Corp (USD) Cardinal Health Inc (USD) Sinopharm Group Co Ltd (USD,CNY) Sinopharm Group Co Ltd (USD,CNY)
Morningstar Rating
Market Cap $Mil
Net Income $Mil
P/S
P/B
P/E
Dividend Yield%
5 Yr Rev CAGR%
Med Oper. Margin%
Interest Coverage
D/E
QQQQ QQQQ QQQQQ
29,461 18,791 16,292 12,305 12,305
67 855 1,696 5,283 5,283
0.1 0.1 0.1 0.3 0.3
3.0 5.9 2.2 2.2 2.2
486.0 22.1 9.8 14.6 14.6
0.9 1.8 3.5 1.7 1.7
11.3 14.4 3.9 15.2 15.2
1.7 1.1 2.0 4.0 4.0
1.8 7.2 4.9 4.9
0.7 1.3 1.2 0.2 0.2
10,952 10,952 10,847 5,285 2,926
3,541 3,541 405 33,199 41
0.4 0.4 0.9 0.2 2.3
1.4 1.4 3.7 1.1 3.2
13.9 14.0 26.0 15.9 34.5
14.0 14.0 6.9 2.2 -12.3
3.7 3.7 7.1 2.6 8.6
6.9 6.9 16.3 174.1 9.3
0.0 0.0 0.3 0.1 0.3
2,903 2,052 1,900 1,900 1,838
41 241 140 140 339
2.4 0.4 0.0 0.4 1.8
3.4 1.4 0.2 2.4 1.6
74.5 8.4 2.1 20.2 5.5
1.1 4.8 32.9 3.7
-12.3 9.6 39.8 39.8 18.7
8.6 7.1 2.9 2.9 29.1
9.3 6.8 10.0 10.0 2.0
0.3 0.6 0.3 0.3 1.7
1,458 1,458 1,010 580 66
13 13 62 55 0
4.1 3.9 0.1 0.2 0.9
5.2 4.9 1.0 1.4
328.0 314.8 16.0 14.1 14.4
0.6
29.8 29.8 1.0 6.8
11.9 11.9 2.3 1.2 -22.1
11.1 11.1
0.6 0.6 0.9 0.0
34 11 3 0
-2 -1 -7 0 -11
1.0
3.6
4.4
1.6
-1,213.8 -446.5 -9.8
-10.2 -3.3
-342.1 -15.8
2.9
Shanghai Pharmaceuticals Holding Co Ltd (USD,CNY) Shanghai Pharmaceuticals Holding Co Ltd (USD,CNY) Henry Schein Inc (USD) QQ Medipal Holdings Corp (USD,JPY) UDG Healthcare PLC (USD) UDG Healthcare PLC (USD) Patterson Companies Inc (USD) Ebos Group Ltd (USD,NZD) Ebos Group Ltd (USD,NZD) Prestige Brands Holdings Inc (USD) Clinigen Group PLC (USD,GBP) Clinigen Group PLC (USD,GBP) Owens & Minor Inc (USD) Sigma Healthcare Ltd (USD,AUD) Fuse Medical Inc (USD)
QQQQ
QQQQ
Synergy CHC Corp (USD) CTT Pharmaceutical Holdings Inc (USD) Nutra Pharma Corp (USD) Scivanta Medical Corp (USD) NOVT Corp (USD)
14.4
1.8 0.7 1.2
6.3 4.0
0.1
-9.9 3.8
Hybrid Energy Holdings Inc (USD) Exlites Holdings International Inc (USD) Global Medical Product Holdings Inc PD-RX Pharmaceuticals Inc China Medicine Corp (USD)
0 0
Itonis Inc (USD) Medex Inc Qian Yuan Baixing Inc (USD) Medirect Latino Inc TGC Ventures International Inc
-1
-5,116.5
0
-7.4
0.7
0.1
9.8 6
China Health Group Ltd (USD,HKD) Pharmagen Inc (USD) Industry Average
23.0
13.2 5.3
44.2
-43 -5 —
6,055
1,715
-21.1 0.2
3.0
21.9
1.7
12.0
©2018 Morningstar. All Rights Reserved. Unless otherwise provided in a separate agreement, you may use this report only in the country in which its original distributor is based. Data as originally reported. The information contained herein is not represented or warranted to be accurate, correct, complete, or timely. This report is for information purposes only, and should not be considered a solicitation to buy or sell any security. Redistribution is prohibited without written permission. To order reprints, call +1 312-696-6100. To license the research, call +1 312-696-6869.
20.4
-135.9 -47.0
-1.0
-232.8
13.1
0.9
®
ß
